Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
An announcement from Harmony Biosciences Holdings (HRMY) is now available.
Jack Bech Nielsen has resigned with immediate effect from the Board of Harmony Biosciences Holdings, Inc. due to health reasons, with no disagreements cited regarding company operations. Meanwhile, Harmony Biosciences Holdings, Inc. has renamed its subsidiary from “Zynerba Pharmaceuticals, Inc.” to “Harmony Biosciences Management, Inc.” as of July 1, 2024.
For detailed information about HRMY stock, go to TipRanks’ Stock Analysis page.
